A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...
1don MSN
Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...
Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...
Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...
“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...
UVA scientists discovered a molecule that blocks a key gene that drives glioblastoma, offering hope for a new treatment ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with NSCLC live longer.
DALLAS — One person’s waste could be another’s shot at fighting cancer. The idea may sound far-fetched, but it is gaining ...
The Crystal Coast area will soon have a new facility to go for extensive cancer care, as the new Carteret Health Care ...
A new World Health Organization study looked at all new cancer cases in 2022 and estimated 37% were linked to preventable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results